KIMBERLY STOTTS: Open Payments
NPI 1528837945 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,865 in 147 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $2,559 · 2025 $2,865
Food & beverage: $2,865
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 29 | $605 |
| Janssen Pharmaceuticals, Inc | 17 | $391 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $299 |
| Otsuka America Pharmaceutical, Inc. | 12 | $267 |
| Neurocrine BioSciences, Inc. | 18 | $262 |
| ABBVIE INC. | 17 | $176 |
| Vanda Pharmaceuticals Inc. | 7 | $169 |
| E.R. Squibb & Sons, L.L.C. | 5 | $156 |
| Lundbeck LLC | 11 | $146 |
| Tris Pharma Inc | 8 | $145 |
Products named: Auvelity, CAPLYTA, INGREZZA, INVEGA SUSTENNA, REXULTI, VRAYLAR, COBENFY, SPRAVATO.
Industry payments across AR — which companies pay providers there.
